CTCF and cancer: In these tissues, tumors may rely on mechanisms involving the Brother of the Regulator of Imprinted Sites (BORIS) to activate telomerase and circumvent CTCF-mediated repression, thus ensuring the unrestricted proliferation of cancer cells [340].